Detalhe da pesquisa
1.
Cancer-Associated Thrombosis: Not All Low-Molecular-Weight Heparins Are the Same, Focus on Tinzaparin, A Narrative Review.
Int J Clin Pract
; 2022: 2582923, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35936060
2.
Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial.
Int J Med Sci
; 18(10): 2245-2250, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33859534
3.
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence.
J Cell Physiol
; 235(11): 7900-7910, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31943171
4.
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.
Int J Cancer
; 146(7): 1917-1929, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31330065
5.
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial.
BMC Med
; 17(1): 207, 2019 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31747948
6.
Efficacy and safety of lenvatinib in an elderly patient with metastatic papillary thyroid carcinoma and cardiological comorbidity: a case report.
Future Oncol
; 15(24s): 27-33, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31393171
7.
Dose intensity and efficacy of the combination of everolimus and exemestane (EVE/EXE) in a real-world population of hormone receptor-positive (ER+/PgR+), HER2-negative advanced breast cancer (ABC) patients: a multicenter Italian experience.
Breast Cancer Res Treat
; 163(3): 587-594, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28353061
8.
Eribulin in Male Patients With Breast Cancer: The First Report of Clinical Outcomes.
Oncologist
; 21(11): 1298-1305, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27742906
9.
Nuclear PARP1 expression and its prognostic significance in breast cancer patients.
Tumour Biol
; 37(5): 6143-53, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26614429
10.
Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study.
Breast Cancer Res Treat
; 147(3): 599-607, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25234842
11.
Biweekly combination of trastuzumab, docetaxel and gemcitabine for HER2-positive metastatic breast cancer: results of a Phase II GOIM study.
Future Oncol
; 10(5): 725-33, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24799054
12.
Explainable 3D CNN based on baseline breast DCE-MRI to give an early prediction of pathological complete response to neoadjuvant chemotherapy.
Comput Biol Med
; 172: 108132, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38508058
13.
The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study.
BMC Cancer
; 13: 56, 2013 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23379680
14.
Abemaciclib-associated Diarrhea: An Exploratory Analysis of Real-life Data.
Anticancer Res
; 43(3): 1291-1299, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36854501
15.
Machine learning survival models trained on clinical data to identify high risk patients with hormone responsive HER2 negative breast cancer.
Sci Rep
; 13(1): 8575, 2023 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37237020
16.
Prognostic power assessment of clinical parameters to predict neoadjuvant response therapy in HER2-positive breast cancer patients: A machine learning approach.
Cancer Med
; 12(22): 20663-20669, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37905688
17.
Analyzing breast cancer invasive disease event classification through explainable artificial intelligence.
Front Med (Lausanne)
; 10: 1116354, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36817766
18.
Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized Trial.
J Clin Oncol
; 41(32): 4976-4981, 2023 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37748109
19.
Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA Study.
Cancers (Basel)
; 16(1)2023 Dec 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38201545
20.
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study.
Front Oncol
; 13: 1152123, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37260975